The data shows a projection of the global biopharma non-cold chain logistics spending from 2016 to 2022. In 2018, this figure is expected to reach 69.3 billion USD. Biopharmaceutical products are extracted or manufactured from biological sources. Common examples include blood and its components, vaccines, and some gene therapies.
2016 | 66 |
2018 | 67.3 |
2020 | 69.3 |
2022 | 73.1 |